Lysulin secures 5th patent for diabetes management supplement The patent protects the formulation’s method it uses to prevent protein glycation.
Lysulin, Inc. recently announced they have secured patent approval for their flagship product Lysulin, a dietary supplement formulated for people with Type 2 diabetes and prediabetes.
“Although the formulation is very simple, it is covered by 5 issued patents. The main ingredients are lysine, zinc and vitamin C. All three ingredients have been individually shown to lower glucose and lysine stops protein glycation,” noted Dr. John Burd, founder & CEO of Lysulin, Inc.
The sponge effect
The company said their all-natural product provides a breakthrough approach for blood glucose management by preventing protein glycation, which is the cause of insulin resistance and type 2 diabetes.